# Novel Nanosensor Array for Detection of Volatile Biomarkers From Skin in Multiple Sclerosis

> **NCT04074629** · NA · COMPLETED · sponsor: **Carmel Medical Center** · enrollment: 107 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DIAGNOSTIC_TEST:** Diagnosis, skin volatile organic compounds (VOCs)

## Key facts

- **NCT ID:** NCT04074629
- **Lead sponsor:** Carmel Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-16
- **Primary completion:** 2022-05-23
- **Final completion:** 2022-08-02
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2022-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04074629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04074629, "Novel Nanosensor Array for Detection of Volatile Biomarkers From Skin in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04074629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*